Occidental Asset Management’s TG Therapeutics TGTX Stock Holding History

Occidental Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$661K	Hold	12,040	–	–	0.07%	171
2026 Q1	$400K	Buy	12,040 +390	+3%	+$11.6K	0.05%	188
2025 Q4	$347K	Buy	11,650 +9	+0.1%	+$294	0.04%	190
2025 Q3	$421K	Sell	11,641 -1	-0%	-$33	0.05%	178
2025 Q2	$419K	Hold	11,642	–	–	0.06%	159
2025 Q1	$459K	Buy	11,642 +19	+0.2%	+$639	0.07%	140
2024 Q4	$350K	Hold	11,623	–	–	0.05%	153
2024 Q3	$272K	Hold	11,623	–	–	0.04%	178
2024 Q2	$207K	Hold	11,623	–	–	0.04%	193
2024 Q1	$177K	Hold	11,623	–	–	0.03%	194
2023 Q4	$199K	Hold	11,623	–	–	0.04%	198
2023 Q3	$97.2K	Hold	11,623	–	–	0.02%	198
2023 Q2	$289K	Hold	11,623	–	–	0.07%	178
2023 Q1	$175K	Hold	11,623	–	–	0.04%	194
2022 Q4	$138K	Hold	11,623	–	–	0.04%	197
2022 Q3	$69K	Hold	11,623	–	–	0.02%	179
2022 Q2	$49K	Hold	11,623	–	–	0.01%	178
2022 Q1	$111K	Hold	11,623	–	–	0.03%	188
2021 Q4	$221K	Hold	11,623	–	–	0.05%	193
2021 Q3	$387K	Hold	11,623	–	–	0.1%	157
2021 Q2	$451K	Sell	11,623 -8,077	-41%	-$317K	0.12%	149
2021 Q1	$950K	Buy	+19,700	New	+$947K	0.28%	94

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Occidental Asset Management's TGTX Position: Q2 2026 in Review

Occidental Asset Management held its TG Therapeutics (TGTX) position steady in Q2 2026 at 12,040 shares worth $661K. The position accounts for 0.07% of the portfolio, ranked #171.

Occidental Asset Management first reported a position in TGTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $950K in Q1 2021. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Occidental Asset Management held 12,040 shares of TG Therapeutics worth $661K as of Q2 2026.
Occidental Asset Management left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up 0.07% of Occidental Asset Management's portfolio in Q2 2026, its #171 holding.
Occidental Asset Management first reported a position in TG Therapeutics in Q1 2021 and has held it in 22 quarters since.
Occidental Asset Management's TG Therapeutics position peaked at $950K in Q1 2021.
429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Occidental Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.